Phase 1 Blood Cancers Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

LeukemiaBlood CancersBlood Cancer+1 more

Jacqueline Garcia, MD31 enrolled2 locationsNCT07148180

Recruiting

Phase 1

CAR T cell therapy for CD19-positive cancer - phase I clinical trial

B cell blood cancers, including non-Hodgkin's lymphoma and leukaemia.

Metro North Hospital and Health Service31 enrolled1 locationACTRN12621000762853